Soni Medicare Ltd

Soni Medicare Ltd (SML) is a micro-cap Healthcare company valued at ₹30 crore operating in Healthcare Services on the NSE and BSE.

Recent price move

Soni Medicare Ltd last traded at ₹69.35, unchanged on the day.

Recent developments

2026-08-16: Mahindra is acquiring SML, aiming to boost its commercial vehicle market share and revenue. 2026-07-30: SML Mahindra was among stocks that surged over 20%, indicating strong investor interest. 2026-06-25: Foreign institutional investors reversed their selling in SML, suggesting a shift in sentiment.

Financial performance

The company's business is deteriorating, with annual revenue falling 12.0% and annual net profit turning into a ₹3 crore loss, widening from a ₹0 crore loss. The latest quarter shows revenue and net profit both declining sharply compared to the same quarter a year earlier, with revenue falling 36.2% and net profit widening from ₹0 crore to ₹1 crore loss. Margins and returns are deeply negative, with net profit margin at -10.3% and return on equity at -14.3%, showing the business is not generating value.

Valuation multiples

A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at -25.20 times book value.

Things to watch

The company's balance sheet is highly leveraged with a debt-to-equity ratio of 7.00, and it has a low interest coverage ratio, making it vulnerable to interest rate hikes. The net profit margin is deeply negative, and the company has high debtors of 177 days, indicating poor cash flow management.

Where it stands

The DocStoX verdict of avoid follows from the company's deeply negative returns, highly leveraged balance sheet, and worsening losses. The most critical factor is the company's inability to generate positive returns, with both revenue and profit declining sharply, and a debt-to-equity ratio that suggests significant financial risk.

Summarised by DocStoX's model on 2026-09-08 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.